IMTX
Price
$5.23
Change
+$0.22 (+4.39%)
Updated
May 2 closing price
Capitalization
635.71M
17 days until earnings call
ROIV
Price
$11.48
Change
-$0.10 (-0.86%)
Updated
May 2 closing price
Capitalization
8.19B
53 days until earnings call
Ad is loading...

IMTX vs ROIV

Header iconIMTX vs ROIV Comparison
Open Charts IMTX vs ROIVBanner chart's image
Immatics
Price$5.23
Change+$0.22 (+4.39%)
Volume$699.05K
Capitalization635.71M
Roivant Sciences
Price$11.48
Change-$0.10 (-0.86%)
Volume$8.77M
Capitalization8.19B
IMTX vs ROIV Comparison Chart
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. ROIV commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and ROIV is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (IMTX: $5.23 vs. ROIV: $11.48)
Brand notoriety: IMTX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 106% vs. ROIV: 121%
Market capitalization -- IMTX: $635.71M vs. ROIV: $8.19B
IMTX [@Biotechnology] is valued at $635.71M. ROIV’s [@Biotechnology] market capitalization is $8.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 6 bullish TA indicator(s).

  • IMTX’s TA Score: 5 bullish, 4 bearish.
  • ROIV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а +15.71% price change this week, while ROIV (@Biotechnology) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

IMTX is expected to report earnings on Aug 12, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.19B) has a higher market cap than IMTX($636M). IMTX has higher P/E ratio than ROIV: IMTX (32.99) vs ROIV (1.97). ROIV YTD gains are higher at: -2.959 vs. IMTX (-26.442). ROIV has higher annual earnings (EBITDA): 4.1B vs. IMTX (-36.26M). ROIV has more cash in the bank: 5.15B vs. IMTX (491M). IMTX has less debt than ROIV: IMTX (16M) vs ROIV (100M). ROIV has higher revenues than IMTX: ROIV (123M) vs IMTX (116M).
IMTXROIVIMTX / ROIV
Capitalization636M8.19B8%
EBITDA-36.26M4.1B-1%
Gain YTD-26.442-2.959894%
P/E Ratio32.991.971,678%
Revenue116M123M94%
Total Cash491M5.15B10%
Total Debt16M100M16%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend about 1 month ago
80%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMAY46.500.54
+1.18%
FT Vest US Equity Buffer ETF May
XBJA28.490.25
+0.87%
Innovator US Eq Acclrtd 9 Bffr ETF Jan
SEPZ37.310.31
+0.84%
TrueShares Structured Outcome Sep ETF
RSPS30.230.15
+0.50%
Invesco S&P 500® Eql Wt Cnsm Stapl ETF
SCHI22.24-0.06
-0.27%
Schwab 5-10 Year Corp Bd ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.86%
IMVT - ROIV
59%
Loosely correlated
-0.63%
ACLX - ROIV
54%
Loosely correlated
+0.03%
KYMR - ROIV
49%
Loosely correlated
+2.11%
CRNX - ROIV
49%
Loosely correlated
+0.72%
DYN - ROIV
49%
Loosely correlated
-1.08%
More